How Much Did Texas Tissue Converting Raise?
Funding & Key Investors

Texas Tissue Converting has successfully secured a major strategic investment, reinforcing its operational capacity within the competitive paper manufacturing sector. This latest infusion of capital brings the firm's total funding to $6.1M, with the most recent financing round contributing $5.1M to the company's balance sheet. This significant debt-based injection underscores the organization's commitment to maintaining high-volume production standards while navigating complex supply chain dynamics.

What is Texas Tissue Converting?

Texas Tissue Converting
ManufacturingPulp & Paper

Texas Tissue Converting operates as a specialized manufacturer within the paper and tissue converting industry, providing essential bath tissue and paper towel products. The company distinguishes itself through a high degree of operational agility, allowing it to pivot rapidly in response to shifting market demands. By prioritizing flexibility and product quality, the firm has established a robust market position, serving as a critical link in the supply chain for high-demand consumer paper goods. Their infrastructure is designed to meet the rigorous requirements of enterprise-level clients, ensuring consistent output and reliable distribution.

How much funding has Texas Tissue Converting raised?

Texas Tissue Converting has raised a total of $6.1M across 2 funding rounds:

2020

Debt

$1M

2024

Debt

$5.1M

Debt (2020): $1M with participation from PPP

Debt (2024): $5.1M led by Bank of America

Key Investors in Texas Tissue Converting

Bank of America

A global financial institution providing comprehensive banking and credit solutions to support large-scale corporate growth and industrial operations.

PPP

Public-Private Partnership

What's next for Texas Tissue Converting?

With the recent influx of capital, Texas Tissue Converting is well-positioned to optimize its manufacturing footprint and enhance its technological capabilities. The strategic allocation of these funds will likely focus on scaling production efficiency and strengthening the company's ability to absorb market volatility. As the firm continues to mature, the focus will shift toward long-term sustainability and the expansion of its market share in the tissue converting space. By leveraging this debt financing, the company aims to solidify its competitive advantage and ensure that its product offerings remain at the forefront of the industry, meeting the evolving needs of its diverse customer base.

See full Texas Tissue Converting company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Manufacturing industry

ManufacturingPlastic, Packaging & ContainersHousehold Goods
ManufacturingTextiles & ApparelApparel & Accessories RetailRetail
ManufacturingWire & CableElectronics
Industrial Machinery & EquipmentManufacturingAerospace & DefenseAutomotive Parts

Frequently Asked Questions Regarding Texas Tissue Converting Financial Insights

What are the most recent funding rounds that Texas Tissue Converting has completed, and what were the funding rounds?
Texas Tissue Converting has recently completed 2 funding rounds: Debt on Dec 31, 2024, Debt on Apr 14, 2020.
What is the total amount of funding Texas Tissue Converting has raised to date?
Texas Tissue Converting has raised a total of $6.1M in funding to date.
How many funding rounds has Texas Tissue Converting completed?
Texas Tissue Converting has completed 2 funding rounds.
How much funding did Texas Tissue Converting raise in its most recent funding round?
Texas Tissue Converting raised $5.1M in its most recent funding round.
Who are the lead investors in Texas Tissue Converting's latest funding round?
The lead investor in Texas Tissue Converting's latest funding round was Bank of America. To access investor data and explore similar companies, sign up for ZoomInfo.
Which was the largest funding round in Texas Tissue Converting's history?
The largest funding round in Texas Tissue Converting's history was $5.1M.
See more information about Texas Tissue Converting